Recurrent Ovarian Cancer
Recurrent Ovarian Cancer occurs when ovarian cancer returns after treatment. This type can be particularly challenging if it is resistant to platinum-based chemotherapy, which is commonly used in treatment.
Ovarian Cancer: ZN-c3 and Niraparib Study
We are studying the safety and effectiveness of a new drug, ZN-c3, alone and with niraparib for patients with platinum-resistant ovarian cancer. This trial aims to find better treatment options for those who have limited choices.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you currently diagnosed with recurrent high grade ovarian cancer or a similar condition?
- Have you had any chemotherapy or targeted therapy in the last 14 days?
- Have you had major surgery in the last 28 days?
- Do you have uncontrolled high blood pressure (systolic over 140 or diastolic over 90)?
- Do you have any known heart problems that cause significant issues, like heart failure?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Azenosertib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut De Cancerologie Strasbourg Europe
Oncologie Médicale
Eckbolsheim, France
Centre Oscar Lambret
Pôle oncologie, comité CCFT
Loos, France
Hospices Civils De Lyon
Oncologie Médicale
Oullins, France
Sponsor: K-Group Beta Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.